Daiwa Securities Group
CRL icon

Daiwa Securities Group’s Charles River Laboratories CRL Stock Holding History

Daiwa Securities Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
12,214
+873
+8% +$155K 0.01% 634
2026
Q1 		$1.96M Buy
11,341
+1,995
+21% +$370K 0.01% 652
2025
Q4 		$1.86M Sell
9,346
-2,287
-20% -$415K 0.01% 667
2025
Q3 		$1.82M Sell
11,633
-1,745
-13% -$277K 0.01% 655
2025
Q2 		$2.03M Buy
13,378
+10,234
+326% +$1.36M 0.01% 615
2025
Q1 		$473K Sell
3,144
-3,676
-54% -$616K ﹤0.01% 835
2024
Q4 		$1.26M Buy
6,820
+465
+7% +$89.6K 0.01% 685
2024
Q3 		$1.25M Buy
6,355
+710
+13% +$148K 0.01% 689
2024
Q2 		$1.17M Buy
5,645
+582
+11% +$132K 0.01% 677
2024
Q1 		$1.37M Buy
5,063
+514
+11% +$123K 0.01% 648
2023
Q4 		$1.07M Buy
4,549
+265
+6% +$52.1K 0.01% 682
2023
Q3 		$840K Buy
4,284
+266
+7% +$54.6K 0.01% 717
2023
Q2 		$845K Buy
4,018
+211
+6% +$42K 0.01% 700
2023
Q1 		$768K Buy
3,807
+200
+6% +$45.3K 0.01% 717
2022
Q4 		$786K Buy
3,607
+200
+6% +$43.7K 0.01% 707
2022
Q3 		$670K Buy
3,407
+178
+6% +$38.4K 0.01% 737
2022
Q2 		$691K Buy
3,229
+28
+0.9% +$6.84K 0.01% 753
2022
Q1 		$909K Buy
3,201
+192
+6% +$59.2K 0.01% 725
2021
Q4 		$1.13M Buy
3,009
+174
+6% +$67.6K 0.01% 672
2021
Q3 		$1.17M Buy
2,835
+56
+2% +$23.3K 0.01% 633
2021
Q2 		$1.03M Buy
+2,779
New +$928K 0.01% 631

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Daiwa Securities Group's CRL Position: Q2 2026 in Review

Daiwa Securities Group increased its Charles River Laboratories (CRL) stake by 7.7% in Q2 2026, buying an estimated $155K and bringing the position to 12,214 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #634.

Daiwa Securities Group first reported a position in CRL in Q2 2021 and has held it in 21 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Daiwa Securities Group held 12,214 shares of Charles River Laboratories worth $2.77M as of Q2 2026.
  • Daiwa Securities Group bought 873 Charles River Laboratories shares in Q2 2026, an estimated $155K.
  • Charles River Laboratories made up 0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #634 holding.
  • Daiwa Securities Group first reported a position in Charles River Laboratories in Q2 2021 and has held it in 21 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.